TABLE 3.
Treatment After uPAR PET/CT (n = 96)
| Treatment | Data |
|---|---|
| Somatostatin analog | 74 (77%) |
| Interferon | 6 (6%) |
| PRRT | 27 (28%) |
| Capecitabine/5-fluorourocil | 10 (10%) |
| Everolimus or sunitinib | 12 (13%) |
| Temozolomide | 8 (8%) |
| Carboplatin or etoposide | 11 (11%) |
| Streptozotocin | 3 (3%) |
| Topotecan | 2 (2%) |
| Docetaxel | 2 (2%) |
| Irinotecan | 1 (1%) |
| Surgery | 9 (9%) |
| Liver embolization | 7 (7%) |
| Liver radiofrequency ablation | 2 (2%) |
| External radiation | 11 (11%) |
Some patients had received more than one treatment; therefore, number of treatments exceeds number of patients. Data are number followed by percentage in parentheses.